RxDoctor Payments Data

George Webb, MD

Family Medicine · Mer Rouge, LANPI 1750481537

Payments from drug & device makers

$4,248in general payments, 2019–2025

Across 281 payments — averaging $15.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$743
  • AstraZeneca$329
  • GSK$328
  • Amgen$319
  • Novo Nordisk$237
  • Lilly USA, LLC$209
  • plus $2K from 39 others

What the payments were for

  • Food & beverage$4,248100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,248 in reported general payments places this provider in the 75th percentile of 1,469 family medicine providers in Louisiana.

See all family medicine providers in Louisiana

Medicare billing

Part B allowed, 2024
$168,741
Medicare patients
375
Services billed
2,918

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide39$39,226
JardianceEmpagliflozin25$33,056
EliquisApixaban32$27,227
Bydureon BciseExenatide Microspheres24$18,092
MounjaroTirzepatide17$17,999
Tresiba Flextouch U-200Insulin Degludec16$14,009
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$11,002
Rosuvastatin Calcium165$1,899
Fluticasone-SalmeterolFluticasone Propion/Salmeterol11$1,754
Colestipol Hcl20$1,692
Amitriptyline Hcl33$1,588
Gabapentin80$1,363
Albuterol Sulfate HfaAlbuterol Sulfate63$1,358
Levothyroxine Sodium116$1,063
Losartan Potassium142$897

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$237$39,22639 claims
Boehringer IngelheimJardiance$71$33,05625 claims
PfizerEliquis$183$27,22732 claims
Lilly USA, LLCMounjaro$209$17,99917 claims
GSKTrelegy Ellipta$328$11,00213 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,469 family medicine providers in Louisiana.

Other family medicine in Mer Rouge

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →